TB-500 · source year

TB-500 research records in 2026

5 selected, source-linked TB-500 records carrying a 2026 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

5 selected records.

Evidence types

3 represented types.

Cited sources

12 distinct public records.

Explore 2026 by evidence type

3 types

Cited chronology

TB-500 records dated 2026

Open in the filterable feed →

July 2026

1 record

April 2026

1 record

Regulatory

Federal Register notice 2026-07361

The Federal Register published notice 2026-07361, attributed to FDA and its parent HHS department, on 2026-04-16. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List,” and PeptideScanner's exact reviewed identity mapping connects the document to BPC-157, Emideltide, Epitalon, KPV, MOTS-c, Semax and TB-500.

Source: Federal Register via GovInfo ↗

March 2026

1 record

January 2026

2 records

Literature metadata

PubMed record PMID 22962027

PeptideScanner retained PubMed bibliographic metadata for PMID 22962027 at 2026-07-30T16:30:49.822Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2012-09-11. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 23084823

PeptideScanner retained PubMed bibliographic metadata for PMID 23084823 at 2026-07-30T16:30:49.836Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2012-10-23. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗